NRx Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has NRx Pharmaceuticals's balance sheet done over the years? Its assets were worth $7,315,000 last year, which is less than in the previous period. 260% of NRx Pharmaceuticalsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $19,048,000, which means an increase by 3% compared compared to last year.

Debt to Assets

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP): Debt to assets
2017 69565819 93.17K 0.13%
2018 70796159 1.25M 1.78%
2019 32074694 2.57M 8.03%
2020 2941000 46.71M 1588.3%
2021 32729000 11.92M 36.43%
2022 25816000 18.40M 71.3%
2023 7315000 19.04M 260.4%

NRXP Balance Sheet (2017 โ€“ 2023)

2023 2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
4.59M20.05M27.60M1.85M611.07K449.37K
Short term investments
0005.96M32.00M70.76M69.02M
Net receivables
6K7K0831K000
Inventory
0-7K0214K000
Other current assets
2.28M5.74M5.10M26K69.48K19.11K87.00K
Total current assets
6.88M25.79M32.71M2.93M69.48K30.19K536.37K
Non-current assets:
Property, Plant and Equipment
0000000
Goodwill
0000000
Intangible assets
0000000
Long term investments
000032.00M71M69.02M
Other non-current assets
431K21K15K11K1-234.03K0
Total non-current assets
431K21K15K11K32.00M70.76M69.02M
Total assets
7.31M25.81M32.72M2.94M32.07M70.79M69.56M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
002.84M0000
Short term debt
9.16M8.70M518K249K000
Total current liabilities
19.04M16.58M11.92M46.16M622.44K567.41K93.17K
Non-current liabilities:
Long term debt
01.82M0548K1.95M690K0
Deferred tax
0000000
Other non-current liabilities
0000000
Total non-current liabilities
01.82M0548K1.95M690K0
Total liabilities
19.04M18.40M11.92M46.71M2.57M1.25M93.17K
Data sourceData sourceData sourceData sourceData sourceData sourceData source